William Blair & Company
LLY icon

William Blair & Company’s Eli Lilly LLY Stock Holding History

William Blair & Company’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-100
Closed -$7K – 1487
2016
Q4 		$7K Buy
+100
New +$7.45K ﹤0.01% 1376

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

William Blair & Company's LLY Position: Q2 2026 in Review

William Blair & Company increased its Eli Lilly (LLY) stake by 7.1% in Q2 2026, buying an estimated $23.6M and bringing the position to 347,098 shares worth $416M. The position accounts for 1.08% of the portfolio, ranked #17.

William Blair & Company first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • William Blair & Company held 347,098 shares of Eli Lilly worth $416M as of Q2 2026.
  • William Blair & Company bought 23,080 Eli Lilly shares in Q2 2026, an estimated $23.6M.
  • Eli Lilly made up 1.08% of William Blair & Company's portfolio in Q2 2026, its #17 holding.
  • William Blair & Company first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
  • 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on William Blair & Company's 13F filing for Q2 2026, filed 11 Aug 2026.